The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I safety and pharmacokinetic study of KN035, the first subcutaneously administered, novel fusion anti-PD-L1 antibody in Japanese patients with advanced solid tumors.
 
Toshio Shimizu
Consulting or Advisory Role - Joint Scientific Committee Review Member for Phase 1 Trials in Hongkong; Takeda/Millennium; The consortium on Harmonization of Institutional Requirements for Clinical Research（CHAIR）
Speakers' Bureau - Boehringer Ingelheim; Chugai Pharma; Ono Pharmaceutical; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - 3D Medicines; Bristol-Myers Squibb; Chordia Therapeutics; Daiichi Sankyo; Eisai; Five Prime Therapeutics; Lilly; Novartis; PharmaMar; SymBio Pharmaceuticals; Takeda/Millennium
Travel, Accommodations, Expenses - Takeda/Millennium
 
Takako Eguchi Nakajima
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Dainippon Sumitomo Pharma; Kyowa Hakko Kirin; Lilly Japan; Maruho; MERCK SERONO; MSD; Ono Pharmaceutical; Sanofi; Sawai Pharmaceutical Co; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - A2 Healthcare; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Eisai; Merck Serono; MSD K.K; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Ni Lu
Employment - 3D Medicines
 
Shilin Xue
Employment - 3D Medicines
 
Wenlian Xu
Employment - 3D Medicines
Stock and Other Ownership Interests - 3D Medicines
 
Meng Fu
Employment - 3D Medicines; MedImmune
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca
 
Walt Cao
Employment - 3D Medicines
Other Relationship - FDA
 
Haolan Lu
Employment - 3D Medicines; Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb (Mexico)
 
David Liu
Employment - 3D Medicines
Stock and Other Ownership Interests - 3D Medicines; Celgene
Other Relationship - 3D Medicines; Celgene
 
RuiPing Dong
No Relationships to Disclose
 
Xiaoxiao Wang
No Relationships to Disclose
 
Pilin Wang
No Relationships to Disclose
 
Danming Zhu
No Relationships to Disclose
 
Ting Xu
No Relationships to Disclose
 
John Gong
No Relationships to Disclose